Skip to main content
logo
Libo Pharma Corp. (TPEX:7888)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.35
-0.05 (-0.17%)
At close: Jul 29, 2026

Libo Pharma Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-296.3-147.8-46.41
Depreciation & Amortization
23.2317.574.89
Other Amortization
0.320.10.12
Stock-Based Compensation
21.6123.60.5
Other Operating Activities
-1.11-0.2-3.17
Change in Accounts Receivable
0.060.233.61
Change in Accounts Payable
13.24-1.034.19
Change in Other Net Operating Assets
-110.15-10.940.31
Operating Cash Flow
-349.1-118.47-35.96
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.56-1.36-0.05
Sale (Purchase) of Intangibles
-0.44-172.24-0.17
Investment in Securities
--44.45
Other Investing Activities
0.03-0.08-
Investing Cash Flow
-0.97-173.6844.23

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Long-Term Debt Repaid
-1.66-1.15-1.05
Net Debt Issued (Repaid)
-1.66-1.15-1.05
Issuance of Common Stock
877.33493.471.08
Financing Cash Flow
875.67492.320.03

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Cash Flow
525.6200.168.3

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Free Cash Flow
-349.66-119.84-36.01
Free Cash Flow Growth
---
Free Cash Flow Per Share
-5.59-2.56-1.36
Levered Free Cash Flow
-246.01-239.68-
Unlevered Free Cash Flow
-245.99-239.65-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash Interest Paid
0.040.050.07
Cash Income Tax Paid
0.390.20.23
Change in Working Capital
-96.84-11.738.11